Immix Biopharma, Inc. (IMMX)
9.31
+0.02
(+0.22%)
USD |
NASDAQ |
Oct 09, 10:34
Immix Biopharma Price to Book Value : 2.909 for Oct. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 08, 2026 | 2.903 |
| October 07, 2026 | 2.966 |
| October 06, 2026 | 3.012 |
| October 05, 2026 | 3.166 |
| October 02, 2026 | 3.025 |
| October 01, 2026 | 3.197 |
| September 30, 2026 | 3.252 |
| September 29, 2026 | 3.294 |
| September 28, 2026 | 3.584 |
| September 25, 2026 | 3.428 |
| September 24, 2026 | 3.656 |
| September 23, 2026 | 3.725 |
| September 22, 2026 | 4.009 |
| September 21, 2026 | 3.897 |
| September 18, 2026 | 3.906 |
| September 17, 2026 | 3.975 |
| September 16, 2026 | 3.725 |
| September 15, 2026 | 3.794 |
| September 14, 2026 | 3.816 |
| September 11, 2026 | 3.794 |
| September 10, 2026 | 3.969 |
| September 09, 2026 | 3.847 |
| September 08, 2026 | 4.141 |
| September 04, 2026 | 4.347 |
| September 03, 2026 | 4.322 |
| Date | Value |
|---|---|
| September 02, 2026 | 4.362 |
| September 01, 2026 | 4.378 |
| August 31, 2026 | 4.384 |
| August 28, 2026 | 4.356 |
| August 27, 2026 | 4.472 |
| August 26, 2026 | 4.397 |
| August 25, 2026 | 4.522 |
| August 24, 2026 | 4.253 |
| August 21, 2026 | 4.269 |
| August 20, 2026 | 4.112 |
| August 19, 2026 | 4.122 |
| August 18, 2026 | 3.691 |
| August 17, 2026 | 3.544 |
| August 14, 2026 | 3.428 |
| August 13, 2026 | 3.412 |
| August 12, 2026 | 3.553 |
| August 11, 2026 | 3.591 |
| August 10, 2026 | 3.166 |
| August 07, 2026 | 3.038 |
| August 06, 2026 | 3.144 |
| August 05, 2026 | 2.981 |
| August 04, 2026 | 2.916 |
| August 03, 2026 | 2.631 |
| July 31, 2026 | 2.60 |
| July 30, 2026 | 2.672 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Atossa Therapeutics, Inc. | 0.9670 |
| ACADIA Pharmaceuticals, Inc. | 2.624 |
| Alnylam Pharmaceuticals, Inc. | 22.97 |
| Savara, Inc. | 7.049 |
| Vericel Corp. | 5.659 |
Price to Book Value Related Metrics
| PEG Ratio | -0.9438 |
| Price | 9.31 |
| Earnings Yield | -9.45% |
| Market Cap | 666.00M |
| PEGY Ratio | -0.9438 |